Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia

Published:2016-03-12 Issue:1 Volume:9 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Feng Zizhen,Yao Yuan,Zhou Chao,Chen Fengju,Wu Fangrui,Wei Liping,Liu Wei,Dong Shuo,Redell Michele,Mo Qianxing,Song Yongcheng

Funder

Cancer Prevention and Research Institute of Texas

National Institute of Neurological Disorders and Stroke

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-016-0252-7.pdf

Reference50 articles.

1. Leukemia Lymphoma Society database. http://www.lls.org/#/diseaseinformation/leukemia/ . Accessed 18 Sept 2015.

2. Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, et al. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group. J Hematol Oncol. 2015;8(1):115.

3. Chen CS, Sorensen PH, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 1993;81(9):2386–93.

4. Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA, et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children’s Oncology Group. Blood. 2006;108(2):441–51.

5. Mrozek K, Heinonen K, Lawrence D, Carroll AJ, Koduru PR, Rao KW, et al. Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood. 1997;90(11):4532–8.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives;Biomarker Research;2024-07-30

2. Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AML;HemaSphere;2024-05

3. Oxytocin alleviated colitis and colitis-associated colorectal tumorigenesis by targeting fucosylated MUC2;2023-08-17

4. Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives;Frontiers in Pharmacology;2023-08-14

5. Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential;Frontiers in Immunology;2023-07-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3